Rx · PZN 03931868, 02140610
LEVODOPA-Carbidopa STADA 200 mg/50 mg prolonged-release tablets
German trade nameLEVODOPA Carbidopa STADA 200 mg-50 mg Retardtabletten
Consistently available
8.3out of 10
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
LEVODOPA-Carbidopa STADA 200 mg/50 mg prolonged-release tablets is consistently available through wholesale. We are happy to review your purchase price and advise you on it.
Review purchasing termsLEVODOPA-Carbidopa STADA 200 mg/50 mg prolonged-release tablets contains the active ingredient Levodopa and decarboxylase inhibitor (German Levodopa und Decarboxylasehemmer*) and comes as Prolonged-release tablets. 2 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 8.1 to 8.3 out of 10. The best-available pack was consistently available.
Pack sizes · 2 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 02140610 | 8.6 | 8.3 | ~ €55 |
| 03931868 | 6.9 | 8.1 | ~ €28 |
We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.
Get in touch